chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: PNC20
Symptoms: Vaccination site cellulitis
Clinical narrative: developed cellulitis after receiving the shot of Prevnar 20/information on where the cellulitis was: left arm at the injection site, in the deltoid; This is a spontaneous report received from contactable reporter(s) (Nurse) from medical information This is a spontaneous report received from contactable reporter(s) (Nurse) from medical information team.  An 86-year-old male patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), as dose number unknown, 0.5ml single (Lot number: GN1898, Expiration Date: Sep2024), in left deltoid for immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing). Concomitant medication(s) included: OMEPRAZOLE; MIDODRINE; POTASSIUM; TAMSULOSIN. The following information was reported: VACCINATION SITE CELLULITIS (intervention required), outcome "unknown", described as "developed cellulitis after receiving the shot of Prevnar 20/information on where the cellulitis was: left arm at the injection site, in the deltoid". Therapeutic measures were taken as a result of vaccination site cellulitis. Additional information: Reporter was wondering if something was wrong with a batch of Prevnar 20 (see lot number below). She has two patients that developed cellulitis after receiving the shot. LOT: GN1898. NDC: 0005 2000 01. Added information on where the cellulitis was for each patient: left arm at the injection site, in the deltoid. Nurse stated, "Our management team had suggested to call as we had 2 patients that actually had developed cellulitis after receiving Prevnar 20. So, my doctor was actually little concerned that there is actually something wrong with the batch because we have given this out numerous times but all of a sudden two patients within a week apart developed cellulitis."  The reporter considered "developed cellulitis after receiving the shot of prevnar 20/information on where the cellulitis was: left arm at the injection site, in the deltoid" associated to pneumococcal 20-val conj vac (dipht CRM197 protein).; Sender's Comments: A possibly contributory role of PREVNAR 20 in triggering the onset of vaccination site cellulitis cannot be fully excluded, considering the temporal relationship.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate,Linked Report(s) : US-PFIZER INC-202300204006 Same reporter, drug, event and different patient;
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Fatigue, Feeling abnormal, Feeling cold
Clinical narrative: she has no strength and wants to sleep; feels lifeless; sweating; freezing; weakness; very tired; fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in May2023 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series completed; but unknown manufacturer), for Covid-19 immunization. The following information was reported: FEELING ABNORMAL (non-serious) with onset May2023, outcome "recovering", described as "feels lifeless"; PYREXIA (non-serious) with onset May2023, outcome "recovering", described as "fever"; FEELING COLD (non-serious) with onset May2023, outcome "unknown", described as "freezing"; HYPERHIDROSIS (non-serious) with onset May2023, outcome "unknown", described as "sweating"; FATIGUE (non-serious) with onset May2023, outcome "recovering", described as "very tired"; ASTHENIA (non-serious) with onset May2023, outcome "unknown", described as "weakness"; SOMNOLENCE (non-serious) with onset 31May2023, outcome "unknown", described as "she has no strength and wants to sleep". The events "very tired", "fever", "she has no strength and wants to sleep" and "feels lifeless" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient had a dose of the Pfizer BioNTech COVID-19 bivalent vaccine and experienced sweating, freezing and weakness. She was very tired. She broke with a 101 degree F fever. She has no strength and wants to sleep. She feels lifeless. She went to the doctor and was feeling better but today (31May2023) she only wants to sleep. She was a healthy woman before. Today (31May2023) was the eighth day since she got the vaccine.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Pyrexia, Somnolence
Clinical narrative: she has no strength and wants to sleep; feels lifeless; sweating; freezing; weakness; very tired; fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in May2023 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series completed; but unknown manufacturer), for Covid-19 immunization. The following information was reported: FEELING ABNORMAL (non-serious) with onset May2023, outcome "recovering", described as "feels lifeless"; PYREXIA (non-serious) with onset May2023, outcome "recovering", described as "fever"; FEELING COLD (non-serious) with onset May2023, outcome "unknown", described as "freezing"; HYPERHIDROSIS (non-serious) with onset May2023, outcome "unknown", described as "sweating"; FATIGUE (non-serious) with onset May2023, outcome "recovering", described as "very tired"; ASTHENIA (non-serious) with onset May2023, outcome "unknown", described as "weakness"; SOMNOLENCE (non-serious) with onset 31May2023, outcome "unknown", described as "she has no strength and wants to sleep". The events "very tired", "fever", "she has no strength and wants to sleep" and "feels lifeless" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient had a dose of the Pfizer BioNTech COVID-19 bivalent vaccine and experienced sweating, freezing and weakness. She was very tired. She broke with a 101 degree F fever. She has no strength and wants to sleep. She feels lifeless. She went to the doctor and was feeling better but today (31May2023) she only wants to sleep. She was a healthy woman before. Today (31May2023) was the eighth day since she got the vaccine.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Sex: F
Vaccine: COVID19, VARZOS
Symptoms: Acoustic stimulation tests, Deafness, Tinnitus
Clinical narrative: Loss of hearing; Tinnitus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation; varicella zoster vaccine rge (cho) (SHINGRIX), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history included: "Allergy to hamster" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DEAFNESS (medically significant), outcome "unknown", described as "Loss of hearing"; TINNITUS (medically significant), outcome "unknown". The events "loss of hearing" and "tinnitus" required physician office visit. The patient underwent the following laboratory tests and procedures: Acoustic stimulation tests: (unspecified date) noise in her ear and loss of hearing; (2021) couldn't have been identical; (2021) no change in hearing test; (2023) sudden lost hearing, notes: The recent hearing test is identical to the other one. Clinical course: Patient was wondering if Pfizer makes Shingrix vaccine. She was trying to figure out if it was the cause or the COVID vaccine. A lot of people were getting the same thing. It could be caused by Shingrix vaccine because it was around the same time. She was having roaring in her ears, basically tinnitus and has seen 2 ENT's and they had the same answer, loss of hearing. Two years ago, she had hearing test and then this time to see what was going on with the noise in her ear and loss of hearing. The recent hearing test was identical to the other one. It was not like she all of a sudden lost hearing and was having tinnitus. It was bothersome and was getting louder. She was trying to figure out how to get rid of it and what could have caused it. Caller's friend's nephew took the COVID shot and he had the same problem, tinnitus. A lot of people are talking about it online and were demanded testing. Caller didn't had the problems two years ago and had regular hearing test. Now with tinnitus they asked for hearing test. They compared the two hearing test and they were identical. It couldn't be identical. It couldn't take 2 years to get tinnitus with no change in hearing test. It might had happened because of the Shingrix. Caller clarified COVID vaccine was the Pfizer COVID vaccine. She was unaware who makes Shingrix. After the Shingrix she got bad asthma and couldn't shake it. She went to allergist and apparently there is hamster in that vaccine and that is what she was allergic to.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300208176 same drug/reporter/AE ,different patient;
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: positive COVID test; positive COVID test; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP), Program ID: (RA). The reporter is the patient. 78-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "recovered", described as "positive COVID test"; COVID-19 (medically significant), outcome "recovered", described as "positive COVID test ". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: she had a positive COVID test last Wednesday; Negative, notes: home tests are now negative. Therapeutic measures were taken as a result of drug ineffective, covid-19. Details were as follows: patient noted that she took both Pfizer COVID vaccines and all available boosters, not otherwise specified then she had a positive COVID test. Her home tests are now negative.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.
Sex: M
Vaccine: COVID19
Symptoms: Amyloidosis, Cerebrovascular accident, Disturbance in attention, Memory impairment, Neoplasm malignant
Clinical narrative: he has cancer, was in surgery recently; suffered a stroke; amyloidosis diagnosis; his memory has been effected; unable to concentrate on details.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  An 83-year-old male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NEOPLASM MALIGNANT (medically significant), outcome "unknown", described as "he has cancer, was in surgery recently"; CEREBROVASCULAR ACCIDENT (medically significant), outcome "unknown", described as "suffered a stroke"; AMYLOIDOSIS (medically significant), outcome "unknown", described as "amyloidosis diagnosis"; MEMORY IMPAIRMENT (non-serious), outcome "unknown", described as "his memory has been effected"; DISTURBANCE IN ATTENTION (non-serious), outcome "unknown", described as "unable to concentrate on details.". Therapeutic measures were taken as a result of neoplasm malignant. Clinical course, reportedly, the patient had cancer, was in surgery recently and suffered a stroke; also stated his memory had been effected and he was unable to concentrate on details. He stated he had taken all of the Pfizer COVID vaccines and believed they had kept him alive through the cancer and now amyloidosis diagnosis. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300097038 same reporter/patient, different AE/drug;
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TINNITUS (non-serious), outcome "unknown".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old male patient received BNT162b2 (BNT162B2), on 28Nov2021 at 15:00 as dose 3 (booster), single (Lot number: FH8030) at the age of 48 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Type 2 Diabetes" (unspecified if ongoing); "High Blood Pressure" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN, start date: 01Apr2020; LOSARTAN, start date: 01Apr2020; ATORVASTATIN, start date: 01Apr2020, stop date: 22May2023. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 22May2023, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (22May2023) Positive; (25May2023) Negative.Therapeutic measures were taken as a result of drug ineffective, covid-19 which included treatment with Paxlovid from 22May2023 to 26May2023.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300207996 same patient, different product/event;
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 62-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 23Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 62 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Neuropathy from a surgery has resulted in pain" (unspecified if ongoing); "poor sleep" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing); "Neuropathy from a surgery has resulted in pain" (not ongoing); "Neuropathy from a surgery has resulted in pain" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Apr2023, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient received COVID 19 Treatment as Paxlovid with start date 23Apr2023 and stop date 27Apr2023.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information provided in the narrative, a causal association between the events and the suspect drug cannot be completely excluded.,Linked Report(s) : US-PFIZER INC-202300208177 same patient, different product/event;
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Drug ineffective; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 68-year-old female patient received BNT162b2 (BNT162B2 NOS), on 23Nov2022 at 10:00 as dose number unknown, single (Batch/Lot number: unknown) at the age of 68 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Diet control DM" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing); "Known allergies: metal" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Known allergies: statins, reaction(s): "Known allergies: Statins". The following information was reported: COVID-19 (medically significant) with onset 2023, outcome "unknown"; DRUG INEFFECTIVE (medically significant) with onset 2023, outcome "unknown". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included treatment with Paxlovid from 20May2023 to 24May2023.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the current available limited information in the case provided, the causal association between the events Drug ineffective , Covid-19 and the use of suspect product comirnaty cannot be fully excluded.,Linked Report(s) : US-PFIZER INC-202300208928 same patient, different drug, different event;
Sex: U
Vaccine: COVID19
Symptoms: Drug ineffective, Suspected COVID-19
Clinical narrative: Covid "fauxccine"-it doesn't work; Covid "fauxccine"-it doesn't work; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Covid "fauxccine"-it doesn't work".  Clinical information:  It was reported that "it doesn't work, it has a laundry list of side-effects, it is EVIL. Whoever reads this, you already know this is true and yet you continue to align yourself with this corrupt organization? The truth is making it's way to the mainstream-it is only a matter of time before everyone knows they were deceived. History will not remember Pfizer fondly - repent and break ties before the inevitable materializes".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received. Follow-up (02Jun2023): Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Blood test, COVID-19, Drug ineffective
Clinical narrative: after a second COVID 19 infection; after a second COVID 19 infection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Type 2 diabetes" (unspecified if ongoing); "I dont exercise" (unspecified if ongoing); "COVID-19 infection" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "after a second COVID 19 infection". The patient underwent the following laboratory tests and procedures: Blood test: Not good, notes: My bloodwork isn't good. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient had Pfizer, his wife had Moderna. Patient did not exercise and his bloodwork was not good, type 2 diabetes etc. After a second COVID 19 infection both decided to use Paxlovid as per (withheld) and many others to help relieve symptoms.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300208142 same patient, different drug/event;US-PFIZER INC-202300208143 same reporter, different drug/event/patients;
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Drug ineffective, Suspected COVID-19
Clinical narrative: I had COVID the first week of May2023; I had COVID the first week of May2023; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset May2023, outcome "unknown" and all described as "I had COVID the first week of May2023".  Clinical course: The patient had COVID the first week of May2023 and the patient enquiring, how long do I wait before getting my next booster shot.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Age: 0.75
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event
Clinical narrative: Paitent has no reaction to the bivalent purple cap with 0.2ml for first dose
Age: 79.0
Sex: M
Vaccine: HEPAB, TDAP, VARZOS
Symptoms: Dysphagia, Hypersensitivity, Lip swelling, Loss of personal independence in daily activities, Mobility decreased
Clinical narrative: Patient came to the pharmacy today on 06/02/2023 stating  he had allergic reactions after receiving the vaccines. Patient states that he started to have swollen arms and itchiness all over his body about 6 hours after receiving the vaccine. He was not able to move his arms or do daily activities for 2 weeks, and pain lasted for month. Patient also states he started to have swollen lips and swollen hard palate on 05/25/2023 (after 23 days of receiving vaccines), which makes him difficult to swallow and eat food.
Age: 79.0
Sex: M
Vaccine: HEPAB, TDAP, VARZOS
Symptoms: Pain, Palatal swelling, Peripheral swelling, Pruritus
Clinical narrative: Patient came to the pharmacy today on 06/02/2023 stating  he had allergic reactions after receiving the vaccines. Patient states that he started to have swollen arms and itchiness all over his body about 6 hours after receiving the vaccine. He was not able to move his arms or do daily activities for 2 weeks, and pain lasted for month. Patient also states he started to have swollen lips and swollen hard palate on 05/25/2023 (after 23 days of receiving vaccines), which makes him difficult to swallow and eat food.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac disorder
Clinical narrative: heart issues
Age: 14.0
Sex: M
Vaccine: COVID19-2
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Patient was administered a Pfizer Bivalent Orange cap ages 5-11 years of age, instead of Pfizer Bivalent Grey cap for 12 years of age and older.
Age: 0.67
Sex: M
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No adverse effects, vaccine given too early
Age: 74.0
Sex: F
Vaccine: RAB, UNK
Symptoms: Exposure to communicable disease, Product administered at inappropriate site
Clinical narrative: Pt was advised to begin rabies post-exposure treatment following a recent encounter with a bat. Pt presented to Urgent Care to receive day  0 doses of RIG and rabies vaccine. Pt reported she received no RIG instilled into her R hand where she had contact with the bat and received all injections in her left deltoid. Pt states she received both RIG and rabies vaccine in the same anatomical site. Contacted DOH who consulted with CDC. Pt advised to repeat day 0 dose of RIG and rabies vaccine, ensuring vaccine was given IM into the R deltoid and RIG given IM into the left thigh.
Age: 0.5
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: pt was given covid 19 mRNA LNP-S bivalent PF 6 mos-5 years (Moderna), 10 mcg/0.2 ml, as a first dose.
Age: 49.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product administration error
Clinical narrative: Reporting due to vaccination administration error. The Moderna COVID-10 vaccine, Bivalent administered today expired yesterday on June 01, 2023. The patient has not experienced any adverse events at this time of reporting.
Age: 77.0
Sex: M
Vaccine: PNC20
Symptoms: Joint swelling, Peripheral swelling
Clinical narrative: Patient reported to the pharmacy that he ad right leg/ankle/foot swelling after the vaccine. He pointed out it was the same side of the body he got his Prevnar 20 injection (right arm).
Age: 42.0
Sex: M
Vaccine: COVID19-2
Symptoms: Anaemia, Condition aggravated, General physical health deterioration
Clinical narrative: I had to (family) history of anemia or pelvic floor dysfunction. Assuming the pelvic floor dysfunction is a result of prolonged anti-biotic prescription, I filed a claim against the local hospital. They were not held responsible by the board of the Department of Health Professionals. As I continue to fight with the symptoms, I was recently diagnosed with anemia. Given the fact that the HCF is not responsible for the cause of the issue, my only other option is to associate the problem with extended reaction to Covid vaccines administered by Pfizer. Over the course of few months after taking the 4th vaccine, I continue to experience new symptoms due to either complications from anti-biotic or Covid vaccines. After doing some research, I noticed that there are some cases of anemia after the administration of Pfizer vaccines that caught my attention.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Cerebrovascular accident, Computerised tomogram head, Confusional state, Death
Clinical narrative: Patient lived independently in own home and was driving independently prior to getting the 4th dose of the Moderna covid19 vaccine. Received vaccine 6/3/22. The following day started with confusion, which progressed in severity. Taken to a local ED on 6/5/22. After evaluation in the ED was admitted to ICU, where she stayed in ICU for several weeks. During hospitalization, she was found to have suffered a severe stroke. After several weeks in the hospital, she was directly transferred to a local rehab center on 7/13/22. While at the rehab center, she was taken to another hospital locally on 8/18. Was inpatient at that facility until 8/31, where she was transferred back to the rehab center. Transferred back to the hospital on 9/7/22 and then to a local hospice center on 9/8/22 and passed away on 9/22/23.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Intensive care, Lumbar puncture, Magnetic resonance imaging, Renal scan, Ultrasound scan
Clinical narrative: Patient lived independently in own home and was driving independently prior to getting the 4th dose of the Moderna covid19 vaccine. Received vaccine 6/3/22. The following day started with confusion, which progressed in severity. Taken to a local ED on 6/5/22. After evaluation in the ED was admitted to ICU, where she stayed in ICU for several weeks. During hospitalization, she was found to have suffered a severe stroke. After several weeks in the hospital, she was directly transferred to a local rehab center on 7/13/22. While at the rehab center, she was taken to another hospital locally on 8/18. Was inpatient at that facility until 8/31, where she was transferred back to the rehab center. Transferred back to the hospital on 9/7/22 and then to a local hospice center on 9/8/22 and passed away on 9/22/23.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray
Clinical narrative: Patient lived independently in own home and was driving independently prior to getting the 4th dose of the Moderna covid19 vaccine. Received vaccine 6/3/22. The following day started with confusion, which progressed in severity. Taken to a local ED on 6/5/22. After evaluation in the ED was admitted to ICU, where she stayed in ICU for several weeks. During hospitalization, she was found to have suffered a severe stroke. After several weeks in the hospital, she was directly transferred to a local rehab center on 7/13/22. While at the rehab center, she was taken to another hospital locally on 8/18. Was inpatient at that facility until 8/31, where she was transferred back to the rehab center. Transferred back to the hospital on 9/7/22 and then to a local hospice center on 9/8/22 and passed away on 9/22/23.
Age: 58.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema
Clinical narrative: Redness 24hrs after injection at site of injection
Age: 0.08
Sex: M
Vaccine: HEP
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Received extra dose of Hep B vac on 3/13/23.  No adverse effects reported
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Injection site erythema
Clinical narrative: MMR AND VARICELLA VACCINES WERE GIVEN ON THE LEFT THIGH. 15 MINUTES AFTER, SMALL RED BUMPS NOTICED ON THE AREA. PATIENT AND PARENTS WERE ESCORTED TO ER AR PER D.R. RINCIOAGA-HUHULEA'S INSTURCTIONS
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Multimorbidity
Clinical narrative: NO NEGATIVE OUTCOME OBSERVED AFTER RECEIVING FIRST DOSE OF COVID VACCINE RESIDENT DIED IN HOUSE AFTER MULTIPLE CO MORBIDITIES PRIOR TO ADMISSION
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Hypoaesthesia, Pain, Paraesthesia, Peripheral swelling
Clinical narrative: Swollen on right arm and the armpit hurts to put arm down, tingling and numbness in right hand
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: EXPIRED VACCINE GIVEN.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired Vaccine given.
Age: 57.0
Sex: F
Vaccine: HEP
Symptoms: Injection site erythema, Injection site nodule, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Felt pain L upper arm on same day of vaccination. Next morning noted "knot" L upper arm, increased in size, became warm/hot and red and itchy. Treatment -> Medrol dose pack, diphenhydramine famotidine.
Age: 57.0
Sex: F
Vaccine: HEP
Symptoms: Injection site warmth
Clinical narrative: Felt pain L upper arm on same day of vaccination. Next morning noted "knot" L upper arm, increased in size, became warm/hot and red and itchy. Treatment -> Medrol dose pack, diphenhydramine famotidine.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Apraxia, Asthenia, Balance disorder, Computerised tomogram, Coordination abnormal
Clinical narrative: Became dizzy within half hour. R eye Headache, threw up, R ear fullness, dizziness kept getting worse - vertigo, vomiting not able to walk. Vertigo looking up, neck pain, R eye impairment floaters, flashes, leg cramps, numbness/pain 4 & 5 fingers, right foot. Got worse ended up in hospital. Oct 3/4-6th. Sent to office for Vestibular PT. NM ENT. Nystagmus. Labrynthtis L ear BPPV Right, hearing loss L/ high frequency both ears, R ear fullness & pain, NM eye specialist-change prescription again nystagmus, ordered a vision field exam. See another neurologist this week. Not able to use the computer without getting sick vertigo keeps returning. Need cane to walk. Ambulation deficits, balance deficits, coordination/proprioception deficits enduranc deficits, pain limiting function, strength deficits transfer deficits, transition deficits, Vestibular deficits visual perceptual deficits, occular flutter, inability to fixate gaze on target. High risk for falls. Lost weight. Tremors - hands, R leg.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Deafness, Dizziness, Ear discomfort, Ear pain, Electrocardiogram
Clinical narrative: Became dizzy within half hour. R eye Headache, threw up, R ear fullness, dizziness kept getting worse - vertigo, vomiting not able to walk. Vertigo looking up, neck pain, R eye impairment floaters, flashes, leg cramps, numbness/pain 4 & 5 fingers, right foot. Got worse ended up in hospital. Oct 3/4-6th. Sent to office for Vestibular PT. NM ENT. Nystagmus. Labrynthtis L ear BPPV Right, hearing loss L/ high frequency both ears, R ear fullness & pain, NM eye specialist-change prescription again nystagmus, ordered a vision field exam. See another neurologist this week. Not able to use the computer without getting sick vertigo keeps returning. Need cane to walk. Ambulation deficits, balance deficits, coordination/proprioception deficits enduranc deficits, pain limiting function, strength deficits transfer deficits, transition deficits, Vestibular deficits visual perceptual deficits, occular flutter, inability to fixate gaze on target. High risk for falls. Lost weight. Tremors - hands, R leg.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Electronystagmogram, Eye disorder, Gait inability, Headache, Hypoaesthesia
Clinical narrative: Became dizzy within half hour. R eye Headache, threw up, R ear fullness, dizziness kept getting worse - vertigo, vomiting not able to walk. Vertigo looking up, neck pain, R eye impairment floaters, flashes, leg cramps, numbness/pain 4 & 5 fingers, right foot. Got worse ended up in hospital. Oct 3/4-6th. Sent to office for Vestibular PT. NM ENT. Nystagmus. Labrynthtis L ear BPPV Right, hearing loss L/ high frequency both ears, R ear fullness & pain, NM eye specialist-change prescription again nystagmus, ordered a vision field exam. See another neurologist this week. Not able to use the computer without getting sick vertigo keeps returning. Need cane to walk. Ambulation deficits, balance deficits, coordination/proprioception deficits enduranc deficits, pain limiting function, strength deficits transfer deficits, transition deficits, Vestibular deficits visual perceptual deficits, occular flutter, inability to fixate gaze on target. High risk for falls. Lost weight. Tremors - hands, R leg.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Illusion, Laboratory test, Labyrinthitis, Loss of personal independence in daily activities, Loss of proprioception
Clinical narrative: Became dizzy within half hour. R eye Headache, threw up, R ear fullness, dizziness kept getting worse - vertigo, vomiting not able to walk. Vertigo looking up, neck pain, R eye impairment floaters, flashes, leg cramps, numbness/pain 4 & 5 fingers, right foot. Got worse ended up in hospital. Oct 3/4-6th. Sent to office for Vestibular PT. NM ENT. Nystagmus. Labrynthtis L ear BPPV Right, hearing loss L/ high frequency both ears, R ear fullness & pain, NM eye specialist-change prescription again nystagmus, ordered a vision field exam. See another neurologist this week. Not able to use the computer without getting sick vertigo keeps returning. Need cane to walk. Ambulation deficits, balance deficits, coordination/proprioception deficits enduranc deficits, pain limiting function, strength deficits transfer deficits, transition deficits, Vestibular deficits visual perceptual deficits, occular flutter, inability to fixate gaze on target. High risk for falls. Lost weight. Tremors - hands, R leg.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging, Muscle spasms, Neck pain, Nystagmus, Pain
Clinical narrative: Became dizzy within half hour. R eye Headache, threw up, R ear fullness, dizziness kept getting worse - vertigo, vomiting not able to walk. Vertigo looking up, neck pain, R eye impairment floaters, flashes, leg cramps, numbness/pain 4 & 5 fingers, right foot. Got worse ended up in hospital. Oct 3/4-6th. Sent to office for Vestibular PT. NM ENT. Nystagmus. Labrynthtis L ear BPPV Right, hearing loss L/ high frequency both ears, R ear fullness & pain, NM eye specialist-change prescription again nystagmus, ordered a vision field exam. See another neurologist this week. Not able to use the computer without getting sick vertigo keeps returning. Need cane to walk. Ambulation deficits, balance deficits, coordination/proprioception deficits enduranc deficits, pain limiting function, strength deficits transfer deficits, transition deficits, Vestibular deficits visual perceptual deficits, occular flutter, inability to fixate gaze on target. High risk for falls. Lost weight. Tremors - hands, R leg.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Photopsia, Tremor, Vertigo, Vertigo positional
Clinical narrative: Became dizzy within half hour. R eye Headache, threw up, R ear fullness, dizziness kept getting worse - vertigo, vomiting not able to walk. Vertigo looking up, neck pain, R eye impairment floaters, flashes, leg cramps, numbness/pain 4 & 5 fingers, right foot. Got worse ended up in hospital. Oct 3/4-6th. Sent to office for Vestibular PT. NM ENT. Nystagmus. Labrynthtis L ear BPPV Right, hearing loss L/ high frequency both ears, R ear fullness & pain, NM eye specialist-change prescription again nystagmus, ordered a vision field exam. See another neurologist this week. Not able to use the computer without getting sick vertigo keeps returning. Need cane to walk. Ambulation deficits, balance deficits, coordination/proprioception deficits enduranc deficits, pain limiting function, strength deficits transfer deficits, transition deficits, Vestibular deficits visual perceptual deficits, occular flutter, inability to fixate gaze on target. High risk for falls. Lost weight. Tremors - hands, R leg.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vestibular disorder, Vitreous floaters, Vomiting, Walking aid user, Weight decreased
Clinical narrative: Became dizzy within half hour. R eye Headache, threw up, R ear fullness, dizziness kept getting worse - vertigo, vomiting not able to walk. Vertigo looking up, neck pain, R eye impairment floaters, flashes, leg cramps, numbness/pain 4 & 5 fingers, right foot. Got worse ended up in hospital. Oct 3/4-6th. Sent to office for Vestibular PT. NM ENT. Nystagmus. Labrynthtis L ear BPPV Right, hearing loss L/ high frequency both ears, R ear fullness & pain, NM eye specialist-change prescription again nystagmus, ordered a vision field exam. See another neurologist this week. Not able to use the computer without getting sick vertigo keeps returning. Need cane to walk. Ambulation deficits, balance deficits, coordination/proprioception deficits enduranc deficits, pain limiting function, strength deficits transfer deficits, transition deficits, Vestibular deficits visual perceptual deficits, occular flutter, inability to fixate gaze on target. High risk for falls. Lost weight. Tremors - hands, R leg.
Age: 87.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: PATIENT WAS POSITIVE FOR COVID 19 ON 11-30-2020, NO FURTHER RE-INFECTION PATIENT DIED 2-14-2022 UNDER HOSPICE CARE, DEATH WAS EXPECTED
Age: 62.0
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest pain, Dizziness, Dyspnoea, Headache, Nausea
Clinical narrative: Date Time PM symptom 1-28-22 4:45 Dizziness/Headache 5:45 Fever -> 101.5 degrees F 6:45 Nausea & vomiting  8:45 Left chest pain w difficulty breathing. 10:45 Sinuses totally bloodied 10:45 BP 190/120/98 11:45 Fever 102.5, lasted till noon 1-31-2022 99.8 12:00 Pulse Oximeter to 90% 12:30  (for my wife)
Age: 62.0
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Paranasal sinus haemorrhage, Pyrexia, Vomiting
Clinical narrative: Date Time PM symptom 1-28-22 4:45 Dizziness/Headache 5:45 Fever -> 101.5 degrees F 6:45 Nausea & vomiting  8:45 Left chest pain w difficulty breathing. 10:45 Sinuses totally bloodied 10:45 BP 190/120/98 11:45 Fever 102.5, lasted till noon 1-31-2022 99.8 12:00 Pulse Oximeter to 90% 12:30  (for my wife)
Age: 0.58
Sex: M
Vaccine: COVID19-2
Symptoms: Wrong product administered
Clinical narrative: The CDC changed the correct Moderna vial, 3 weeks after the state changed to all patients get Bivalent COVID vaccines. The correct vials were not available or available to order, at the time the state implemented this change.
Age: 0.5
Sex: F
Vaccine: COVID19-2
Symptoms: Wrong product administered
Clinical narrative: The CDC changed the correct Moderna vial, 3 weeks after the state changed to all patients get Bivalent COVID vaccines. The correct vials were not available or available to order, at the time the state implemented this change.
Age: 0.58
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: The CDC changed the correct Moderna vial, 3 weeks after the State changed to all patients get Bivalent COVID vaccines. The correct vials were not available or available to order, at the time the State implemented this change.
Age: 4.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: The CDC changed the correct Moderna vial, 3 weeks after the State changed to all patients get Bivalent COVID vaccines. The correct vials were not available or available to order, at the time the State implemented this change.
Age: 4.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: The CDC changed the correct Moderna vial 3 weeks after the state changed to all patients get Bivalent Covid vaccines. The correct vials were not available or available to order, at the time the state implemented this change.
Age: 0.58
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: The CDC changed the correct Moderna vial, 3 weeks after the State changed to all patients get Bivalent COVID vaccines. The correct vials were not available or available to order, at the time the State implemented this change.
Age: 0.58
Sex: M
Vaccine: COVID19-2
Symptoms: Discontinued product administered
Clinical narrative: The CDC changed the correct Moderna vial, 3 weeks after the State changed to all patients get Bivalent COVID vaccines. The correct vials were not available or available to order, at the time the State implemented this change.
Age: 0.83
Sex: U
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: The CDC changed the correct Moderna vial, 3 weeks after the State changed to all patients get Bivalent COVID vaccines. The correct vials were not available or available to order, at the time the State implemented this change.
Age: 0.5
Sex: F
Vaccine: COVID19-2
Symptoms: Discontinued product administered
Clinical narrative: The CDC changed the correct Moderna vial, 3 weeks after the State changed to all patients get Bivalent COVID vaccines. The correct vials were not available or available to order, at the time the State implemented this change.
Age: 0.58
Sex: M
Vaccine: COVID19-2
Symptoms: Product supply issue
Clinical narrative: The CDC changed the correct Moderna vial, 3 weeks after the State changed to all patients get Bivalent COVID vaccines. The correct vials were not available or available to order, at the time the State implemented this change.
Age: 0.67
Sex: M
Vaccine: COVID19-2
Symptoms: Discontinued product administered
Clinical narrative: The CDC changed the correct Moderna vial, 3 weeks after the State changed to all patients get Bivalent COVID vaccines. The correct vials were not available or available to order, at the time the State implemented this change.
Age: 2.08
Sex: F
Vaccine: COVID19-2
Symptoms: Discontinued product administered
Clinical narrative: The CDC changed the correct Moderna vial, 3 weeks after the State changed to all patients get Bivalent COVID vaccines. The correct vials were not available or available to order, at the time the State implemented this change.
Age: 0.5
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: The CDC changed the correct Moderna vial, 3 weeks after the State changed to all patients get Bivalent COVID vaccines. The correct vials were not available or available to order, at the time the State implemented this change.
Age: 1.83
Sex: M
Vaccine: COVID19-2
Symptoms: Discontinued product administered
Clinical narrative: The CDC changed the correct Moderna vial, 3 weeks after the State changed to all patients get Bivalent COVID vaccines. The correct vials were not available or available to order, at the time the State implemented this change.
Age: 2.0
Sex: M
Vaccine: COVID19-2
Symptoms: Discontinued product administered
Clinical narrative: The CDC changed the correct Moderna vial, 3 weeks after the State changed to all patients get Bivalent COVID vaccines. The correct vials were not available or available to order, at the time the State implemented this change.
Sex: U
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: The CDC changed the correct Moderna vial, 3 weeks after the State changed to all patients get Bivalent COVID vaccines. The correct vials were not available or available to order, at the time the State implemented this change.